TVT 2021 – High-Risk Severe Aortic Regurgitation with TAVR: Panel Discussion

761 views
December 21, 2021
Learn about the undertreatment of aortic regurgitation, the importance of echocardiography in diagnosing severe AR, and the possibility of TAVR as an option for high-risk, severe AR patients through the active ALIGN-AR Trial.

The Trilogy Heart Valve System is not for sale in the US and is limited by Federal (or United States) law to investigational use.

0 Comments
Login to view comments. Click here to Login